Hiya, Orphan Drug Status to my knowledge has not been referred to in any PRR release since last november in the 2009 AGM Presentation under the subheading "FDA Approval Timeline"
Achievements to date...(part only)
US FDA pre-Investigational New Drug Application (preIND)
meeting concluded October 2008
A PreIND meeting is a key milestone in FDA approval process
IND application for CVac submitted July 2009
FDA approval to begin Phase IIb clinical trial granted Aug 2009
Upcoming...
Multicentre Phase IIb clinical trial to commence early 2010
Clinical trial to be conducted on total of 60 patients
Orphan Drug Designation for CVac ovarian cancer treatment
Allows the FDA to expedite the final drug review approval process
It was also mentioned in the Investor Presentation held back in august under the same heading. Dcheckers noted in his excellent summation of that same meeting and welcome to new investors (post 4420222) that ODS approval was expected after granting of the IND.
As the phase 11B trials were to have originally commenced in late 2009, the expectation of obtaining ODS in approx 6 months presumably has slipped also. The FDA timeline suggests it won't happen until after these trials are "conducted" quite aside from the IND approval scenario.
I am thinking that any ODS announcement won't be imminent or am I misreading this?
Any thoughts?
cheers
billdah
http://www.asx.com.au/asxpdf/20091130/pdf/31mf8y2wxvc642.pdf
- Forums
- ASX - By Stock
- IMM
- provenge a 65/35 chance of approval
provenge a 65/35 chance of approval, page-19
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.005(1.59%) |
Mkt cap ! $465.4M |
Open | High | Low | Value | Volume |
31.0¢ | 32.5¢ | 31.0¢ | $743.7K | 2.332M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 251674 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 100642 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 251674 | 0.315 |
10 | 684820 | 0.310 |
14 | 271834 | 0.305 |
27 | 586638 | 0.300 |
8 | 152248 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 97566 | 6 |
0.330 | 101975 | 3 |
0.335 | 96276 | 5 |
0.340 | 43046 | 2 |
0.345 | 111753 | 4 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online